FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients

被引:0
作者
Peter A Fasching
Sebastian M Jud
Maik Hauschild
Sherko Kümmel
Martin Schütte
Matthias Warm
Volker Hanf
Dieter Grab
Jutta Krocker
Elmar Stickeler
Rolf Kreienberg
Thomas Müller
Thorsten Kühn
Christopher Wolf
Steffen Kahlert
Stefan Paepke
Michael Berghorn
Mathias Muth
Monika Baier
Birgit Wackwitz
Rüdiger Schulz-Wendtland
Matthias W Beckmann
Michael P Lux
机构
[1] Erlangen Comprehensive Cancer Center Erlangen-EMN,University Breast Center, Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen–Nuremberg
[2] Departement of Gynecology and Obstetrics,Department of Gynecology and Obstetrics
[3] Breast Center,Department of Gynecology and Obstetrics
[4] Klinikum Essen-Mitte,Department of Gynecology and Obstetrics
[5] Essen University Hospital,Department of Gynecology and Obstetrics
[6] Cologne University Hospital,Department of Gynecology and Obstetrics
[7] Kliniken der Stadt Köln Holweide,Department of Gynecology and Obstetrics
[8] Clinic for Gynecology and Obstetrics "Nathanstift" Klinikum Fürth,Department of Gynecology and Obstetrics
[9] Klinikum Harlaching,Frauenklinik Grosshadern
[10] Sana-Klinikum Lichtenberg,Institute of Diagnostic Radiology, Erlangen University Hospital
[11] Oskar-Ziethen-Krankenhaus,undefined
[12] Freiburg University Hospital,undefined
[13] Ulm University Hospital,undefined
[14] Frauenklinik,undefined
[15] Klinikum Hanau,undefined
[16] Klinikum Esslingen,undefined
[17] Medizinisches Zentrum Ulm,undefined
[18] Frauenklinik und Poliklinik der Technischen Universität München,undefined
[19] Universitätsklinik der Ludwig-Maximilians-Universität,undefined
[20] Frauenklinik,undefined
[21] Allgemeines Krankenhaus Celle,undefined
[22] Novartis Pharma GmbH,undefined
[23] Friedrich Alexander University of Erlangen–Nuremberg,undefined
来源
BMC Cancer | / 14卷
关键词
Zoledronic acid; Neoadjuvant treatment; Breast cancer; Letrozole; Aromatase inhibitors; Bisphosphonates;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 226 条
[11]  
Ural AU(2006)A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates Br J Pharmacol 147 437-445
[12]  
Avcu F(2003)Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells J Urol 170 246-252
[13]  
Baran Y(2003)New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects Br J Canc 88 1631-1640
[14]  
Coleman RE(2011)Zoledronic Acid in Adjuvant Therapy of Receptor Negative Early Breast Cancer - Rationale and First Experience in Individual Therapy Strategy Geburtsh Frauenheilk 71 135-139
[15]  
Marshall H(2012)Analysis of molecular mechanisms and anti-tumoral effects of zoledronic acid in breast cancer cells J Cell Mol Med 16 2186-2195
[16]  
Cameron D(2012)Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer Ann Oncol Off J Euro Soc Med Oncol ESMO 23 597-604
[17]  
Dodwell D(2000)New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205-216
[18]  
Burkinshaw R(2005)Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself* Breast Canc Res Treat 94 17-23
[19]  
Keane M(2005)Neoadjuvant chemotherapy in breast cancer: which diagnostic procedures can be used? Anticancer Res 25 2519-2525
[20]  
Gil M(2011)Assessment of breast cancer tumour size using six different methods Eur Radiol 21 1180-1187